Literature DB >> 20213125

Early onset multiple myeloma in a patient with systemic lupus erythematosus: a case report and literature review.

Jin Woo Choi1, Seung Woo Han, Ki Tae Kwon, Gun Woo Kim.   

Abstract

Patients with systemic lupus erythematosus (SLE) are at increased risk for various plasma cell dyscrasias, but the coexistence of SLE and multiple myeloma (MM) are rarely reported to date. Due to the rarity, the clinical features of MM associated with SLE have not been elucidated, and the pathogenesis under this association remains unclear. In this report, we investigate a 31-year-old woman with 5-year history of SLE, who is diagnosed as IgA λ-type MM with multiple lymph node involvement. We discuss the clinical features of MM in SLE by reviewing previous cases and possible mechanisms connecting the two conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213125     DOI: 10.1007/s10067-010-1417-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Multiple myeloma associated with systemic lupus erythematosus.

Authors:  George Vaiopoulos; Kostas Konstantopoulos; Marina Mantzourani; Phaedon Kaklamanis
Journal:  Leuk Lymphoma       Date:  2003-02

2.  Systemic lupus erythematosus in association with smoldering multiple myeloma.

Authors:  E Sendagorta; J Matarredona; J A Brieva; M L Rodríguez; A Ledo
Journal:  J Am Acad Dermatol       Date:  1987-01       Impact factor: 11.527

3.  Malignancy in a series of 70 patients with systemic lupus erythematosus.

Authors:  J J Canoso; A S Cohen
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

Review 4.  Systemic lupus erythematosus and multiple myeloma: a rare association.

Authors:  A Afeltra; A Amoroso; P Garzia; M A Addessi; A Pulsoni; L Bonomo
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

5.  Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

Authors:  Anne J Novak; Jaime R Darce; Bonnie K Arendt; Brandon Harder; Kathy Henderson; Wayne Kindsvogel; Jane A Gross; Philip R Greipp; Diane F Jelinek
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

6.  Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

Authors:  Halina Urbańska-Ryś; Ewa Robak; RadzisŁaw Kordek; Jacek Bartkowiak; Piotr Rieske; Anna Woźniacka; Piotr Smolewski; Tadeusz Robak
Journal:  Leuk Lymphoma       Date:  2004-09

7.  Monoclonal gammopathy in systemic lupus erythematosus.

Authors:  Y M Ali; M B Urowitz; D Ibanez; D D Gladman
Journal:  Lupus       Date:  2007       Impact factor: 2.911

8.  Multiple myeloma complicating the course of seronegative systemic lupus erythematosus.

Authors:  E Jordan; S L Burnstein; J J Calabro; E S Henderson
Journal:  Arthritis Rheum       Date:  1978-03

9.  Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?

Authors:  J Bila; N Suvajdzic; I Elezovic; M Colovic; D Boskovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.738

10.  Monoclonal macroglobulinemia in NZB-NZW F1 mice.

Authors:  S Sugai; R Pillarisetty; N Talal
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  3 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Non-lymphoma hematological malignancies in systemic lupus erythematosus.

Authors:  Mary Lu; Sasha Bernatsky; Rosalind Ramsey-Goldman; Michelle Petri; Susan Manzi; Murray B Urowitz; Dafna Gladman; Paul R Fortin; Ellen M Ginzler; Edward Yelin; Sang-Cheol Bae; Daniel J Wallace; Soren Jacobsen; Mary Anne Dooley; Christine A Peschken; Graciela S Alarcón; Ola Nived; Lena Gottesman; Lindsey A Criswell; Gunnar Sturfelt; Lene Dreyer; Jennifer L Lee; Ann E Clarke
Journal:  Oncology       Date:  2013-10-02       Impact factor: 2.935

3.  Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).

Authors:  Li Pang; S Vincent Rajkumar; Prashant Kapoor; Francis Buadi; Angela Dispenzieri; Morie Gertz; Martha Lacy; Robert Kyle; Shaji Kumar
Journal:  Blood Cancer J       Date:  2021-02-01       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.